These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19580345)

  • 1. Acute lymphoblastic leukemia-derived dendritic cells express tumor associated antigens: PNPT1, PMPCB, RHAMM, BSG and ERCC1.
    Luczynski W; Kowalczuk O; Stasiak-Barmuta A; Ilendo E; Krawczuk-Rybak M; Chyczewski L
    Neoplasma; 2009; 56(5):428-34. PubMed ID: 19580345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40L and IL-4 stimulation of acute lymphoblastic leukemia cells results in upregulation of mRNA level of FLICE--an important component of apoptosis.
    łuczyński W; Kowalczuk O; Iłendo E; Stasiak-Barmuta A; Krawczuk-Rybak M; Malinowska I; Kołtan A; Szczepalński T; Olejnik I; Jaworowski R; Chyczewski L; Matysiak M; Wysocki M; Sońta-Jakimczyk D; Wieczorek M
    Folia Histochem Cytobiol; 2007; 45(1):15-20. PubMed ID: 17378240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40 stimulation induces differentiation of acute lymphoblastic leukemia cells into dendritic cells.
    Luczyński W; Stasiak-Barmuta A; Iłendo E; Krawczuk-Rybak M; Malinowska I; Mitura-Lesiuk M; Parfieńczyk A; Szymański M
    Acta Biochim Pol; 2006; 53(2):377-82. PubMed ID: 16733557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of antigen-processing machinery components at mRNA level in acute lymphoblastic leukemia cells after CD40 stimulation.
    Luczyński W; Kowalczuk O; Iłendo E; Stasiak-Barmuta A; Krawczuk-Rybak M
    Ann Hematol; 2007 May; 86(5):339-45. PubMed ID: 17285277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells.
    Willemen Y; Van den Bergh JM; Bonte SM; Anguille S; Heirman C; Stein BM; Goossens H; Kerre T; Thielemans K; Peeters M; Van Tendeloo VF; Smits EL; Berneman ZN
    Oncotarget; 2016 Nov; 7(45):73960-73970. PubMed ID: 27659531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute lymphoblastic leukaemia cells express CCR7 but not higher amounts of IL-10 after CD40 ligation.
    Luczyński W; Iłendo E; Kovalchuk O; Krawczuk-Rybak M; Malinowska I; Kołtan A; Szczepański T; Wysocka J; Jaworowski R; Olejnik I; Chyczewski L; Matysiak M; Wysocki M; Sońta-Jakimczyk D; Wieczorek M
    Scand J Clin Lab Invest; 2006; 66(8):695-703. PubMed ID: 17101562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens.
    Li L; Reinhardt P; Schmitt A; Barth TF; Greiner J; Ringhoffer M; Döhner H; Wiesneth M; Schmitt M
    Cancer Immunol Immunother; 2005 Jul; 54(7):685-93. PubMed ID: 15627212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of potent T(h)1 responses from patients with lymphoid malignancies after differentiation of B lymphocytes into dendritic-like cells.
    Mohty M; Isnardon D; Charbonnier A; Lafage-Pochitaloff M; Merlin M; Sainty D; Olive D; Gaugler B
    Int Immunol; 2002 Jul; 14(7):741-50. PubMed ID: 12096033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia.
    Greiner J; Ringhoffer M; Taniguchi M; Schmitt A; Kirchner D; Krähn G; Heilmann V; Gschwend J; Bergmann L; Döhner H; Schmitt M
    Exp Hematol; 2002 Sep; 30(9):1029-35. PubMed ID: 12225794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.
    Snauwaert S; Vanhee S; Goetgeluk G; Verstichel G; Van Caeneghem Y; Velghe I; Philippé J; Berneman ZN; Plum J; Taghon T; Leclercq G; Thielemans K; Kerre T; Vandekerckhove B
    Haematologica; 2012 Oct; 97(10):1539-47. PubMed ID: 22532518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Li L; Schmitt A; Reinhardt P; Greiner J; Ringhoffer M; Vaida B; Bommer M; Vollmer M; Wiesneth M; Döhner H; Schmitt M
    Cancer Immun; 2003 Jul; 3():8. PubMed ID: 12862419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute lymphoblastic leukemia cells treated with CpG oligodeoxynucleotides, IL-4 and CD40 ligand facilitate enhanced anti-leukemic CTL responses.
    Fabricius D; Breckerbohm L; Vollmer A; Queudeville M; Eckhoff SM; Fulda S; Strauss G; Debatin KM; Jahrsdörfer B; Meyer LH
    Leukemia; 2011 Jul; 25(7):1111-21. PubMed ID: 21527935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy.
    D'Amico G; Bonamino M; Dander E; Marin V; Basso G; Balduzzi A; Biagi E; Biondi A
    Leukemia; 2006 Nov; 20(11):2015-24. PubMed ID: 16990769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia.
    Giannopoulos K; Li L; Bojarska-Junak A; Rolinski J; Dmoszynska A; Hus I; Greiner J; Renner C; Döhner H; Schmitt M
    Int J Oncol; 2006 Jul; 29(1):95-103. PubMed ID: 16773189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA loading of leukemic antigens into cord blood-derived dendritic cells for immunotherapy.
    Hsu AK; Kerr BM; Jones KL; Lock RB; Hart DN; Rice AM
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):855-67. PubMed ID: 16864056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of costimulatory molecules and mRNA for cytokines are important mechanisms of immunosuppression in acute lymphoblastic leukemia in children?
    Luczyński W; Stasiak-Barmuta A; Iłendo E; Kovalchuk O; Krawczuk-Rybak M; Malinowska I; Mitura-Lesiuk M; Chyczewski L; Matysiak M; Kowalczyk J; Jaworowski R
    Neoplasma; 2006; 53(4):301-4. PubMed ID: 16830056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia.
    Todisco E; Gaipa G; Biagi E; Bonamino M; Gramigna R; Introna M; Biondi A
    Leukemia; 2002 Oct; 16(10):2046-54. PubMed ID: 12357356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods of dendritic cell preparation for acute lymphoblastic leukemia immunotherapy in children.
    Pospísilová D; Borovicková J; Rozková D; Stary J; Seifertová D; Tobiásová Z; Spísek R; Bartunková J
    Med Oncol; 2005; 22(1):79-88. PubMed ID: 15750200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovector-induced expression of human-CD40-ligand (hCD40L) by multiple myeloma cells. A model for immunotherapy.
    Dotti G; Savoldo B; Takahashi S; Goltsova T; Brown M; Rill D; Rooney C; Brenner M
    Exp Hematol; 2001 Aug; 29(8):952-61. PubMed ID: 11495701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.